Apollon Wealth Management LLC boosted its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 48.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,641 shares of the financial services provider's stock after buying an additional 4,423 shares during the period. Apollon Wealth Management LLC's holdings in CME Group were worth $2,873,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the stock. Stratos Wealth Partners LTD. raised its stake in CME Group by 4.7% in the third quarter. Stratos Wealth Partners LTD. now owns 2,452 shares of the financial services provider's stock valued at $491,000 after buying an additional 111 shares in the last quarter. Brown Advisory Inc. boosted its holdings in CME Group by 0.6% in the third quarter. Brown Advisory Inc. now owns 15,237 shares of the financial services provider's stock valued at $3,051,000 after purchasing an additional 84 shares in the last quarter. IFM Investors Pty Ltd boosted its holdings in CME Group by 2.7% in the third quarter. IFM Investors Pty Ltd now owns 73,727 shares of the financial services provider's stock valued at $14,762,000 after purchasing an additional 1,948 shares in the last quarter. Waldron Private Wealth LLC raised its stake in CME Group by 3.5% during the 3rd quarter. Waldron Private Wealth LLC now owns 2,684 shares of the financial services provider's stock worth $537,000 after acquiring an additional 92 shares in the last quarter. Finally, Foyston Gordon & Payne Inc lifted its position in CME Group by 41.4% in the third quarter. Foyston Gordon & Payne Inc now owns 18,168 shares of the financial services provider's stock valued at $3,638,000 after acquiring an additional 5,319 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Wall Street Analyst Weigh In
CME has been the topic of several research reports. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $198.00 to $206.00 and gave the stock a "neutral" rating in a research report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Morgan Stanley upped their price target on CME Group from $222.00 to $225.00 and gave the stock an "equal weight" rating in a research note on Tuesday, April 9th. Bank of America lifted their price objective on shares of CME Group from $209.00 to $216.00 and gave the company a "neutral" rating in a research report on Thursday, April 25th. Finally, Argus upped their price target on shares of CME Group from $225.00 to $245.00 and gave the stock a "buy" rating in a research note on Wednesday, March 6th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group currently has an average rating of "Hold" and a consensus price target of $217.80.
Read Our Latest Stock Analysis on CME Group
CME Group Trading Up 0.2 %
NASDAQ:CME traded up $0.34 during mid-day trading on Tuesday, reaching $208.34. The company's stock had a trading volume of 2,130,585 shares, compared to its average volume of 1,787,588. CME Group Inc. has a twelve month low of $175.73 and a twelve month high of $223.80. The company's fifty day simple moving average is $213.87 and its two-hundred day simple moving average is $211.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market cap of $75.00 billion, a P/E ratio of 23.66, a P/E/G ratio of 5.19 and a beta of 0.48.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.44 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. CME Group's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.42 earnings per share. On average, equities analysts predict that CME Group Inc. will post 9.72 EPS for the current year.
CME Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date was Thursday, March 7th. This is an increase from CME Group's previous quarterly dividend of $1.10. CME Group's dividend payout ratio is 52.33%.
Insider Activity at CME Group
In other news, CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the completion of the sale, the chief executive officer now owns 67,455 shares in the company, valued at $14,226,934.05. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.30% of the stock is currently owned by insiders.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
